Skip to main content

Leonteq Securities AG

Broker-Dealer

Position in VKTX — Viking Therapeutics, Inc.

CIK 1535950 ZURICH, V8

Position in VKTX

as of Jun 30, 2026 · filed Jul 27, 2026
Position Value
$602,977
-$139,325 QoQ
Shares Held
15,457
-32.2% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#200
of 434 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Derivatives in VKTX

reported options exposure · as of Sep 30, 2025
CallValue
$105,120
CallShares
4,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Leonteq Securities AG holds $31,066,022 across 58 Biotechnology names. VKTX ranks #8 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 VKTX
Viking Therapeutics, Inc.
This page
15,457 $602,977

All Filings in VKTX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $602,977 15,457
2026-03-31 $742,302 22,812
2025-12-31 $487,629 13,861
2025-09-30 $371,993 14,155
2025-09-30 $105,120 4,000
2025-06-30 $254,559 9,606
2025-03-31 $377,875 15,647
2024-12-31 $457,448 11,368
2024-09-30 $510,215 8,059
2024-06-30 $233,456 4,404
2024-03-31 $250,756 3,058
2023-12-31 $1,861 100